Advertisement

Person › Details
Niels C. Riedemann (InflaRx GmbH)
Riedemann, Niels C. (InflaRx 200803 Managing Director + founder)
![]() |
Organisation | InflaRx GmbH |
Group | InflaRx (Group) | |
![]() |
Product | anti-inflammatory drug |
Record changed: 2024-02-23 |
Advertisement

More documents for Niels C. Riedemann
- [1] InflaRx N.V.. (6/24/24). "Press Release: InflaRx’s Gohibic (vilobelimab) Selected for First BARDA-sponsored Clinical Trial to Evaluate Novel Host-directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)". Jena....
- [2] InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena....
- [3] InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI....
- [4] InflaRx N.V.. (4/4/23). "Press Release: InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients". Jena....
- [5] InflaRx N.V.. (12/21/22). "Press Release: InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19". Jena....
- [6] InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena....
- [7] InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top